| |
Latest 10 SEC filings (by transaction date) for IGMS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 28/24 | Mar 28/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 89,407 | $9.62 |
Mar 28/24 | Mar 28/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 8,066 | $9.62 |
Mar 28/24 | Mar 27/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 8,439 | $9.27 |
Mar 28/24 | Mar 27/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 761 | $9.27 |
Mar 28/24 | Mar 27/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 17,101 | $9.22 |
Mar 28/24 | Mar 27/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 1,543 | $9.22 |
Mar 28/24 | Mar 26/24 | Schwarzer Fred | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 38,583 | |
Mar 28/24 | Mar 26/24 | Keyt Bruce | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 24,019 | |
Mar 28/24 | Mar 26/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 247,656 | $8.26 |
Mar 28/24 | Mar 26/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 22,344 | $8.26 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for IGMS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 28/24 | Mar 26/24 | Schwarzer Fred | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 38,583 | |
Mar 28/24 | Mar 26/24 | Keyt Bruce | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 24,019 | |
Mar 28/24 | Mar 28/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 89,407 | $9.62 |
Mar 28/24 | Mar 28/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 8,066 | $9.62 |
Mar 28/24 | Mar 27/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 8,439 | $9.27 |
Mar 28/24 | Mar 27/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 761 | $9.27 |
Mar 28/24 | Mar 27/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 17,101 | $9.22 |
Mar 28/24 | Mar 27/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 1,543 | $9.22 |
Mar 28/24 | Mar 26/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 247,656 | $8.26 |
Mar 28/24 | Mar 26/24 | Baker Bros. Advisors Lp | Indirect Ownership | Common Stock | P - Open market or private purchase | 22,344 | $8.26 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cerevel Therapeutics Hold (OQ:CERE) |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |